Auauniversity

AUA2023: Refractory Overactive Bladder: How To Select 3rd Line Therapies and Optimize Outcomes

Informações:

Sinopsis

AUA2023: Refractory Overactive Bladder: How To Select 3rd Line Therapies and Optimize Outcomes CME Available: https://auau.auanet.org/node/38287 CME Expiration Date: May, 2024 ACKNOWLEDGEMENTS Independent educational grant support provided by: Astellas Urovant Sciences, Inc.